Building World Changing Enterprises
Providing corporate advisory services and capital to companies with an entrepreneurial flair that are either listed or preparing to list on the ASX
About Cadmon
We firmly believe in the transformative power of innovation, and endeavor to launch new projects with the power to disrupt established industries and to bring novel concepts to untapped markets.
Cadmon Advisory
We provide strategic advisory, capital markets and business development services to our clients, as one of the few institutional grade corporate advisors specialising in concept and frontier technology companies on the ASX.
Cadmon Ventures
We invest in startups and business ventures that endeavour to solve global problems through innovation. We incubate and launch our own start-up initiatives across an array of industries in collaboration with world class researchers.
Cadmon Advisory
We specialise in early stage, concept and frontier technology companies. Our ‘funds management’ roots give you access to a truly unique perspective into an investor’s mind.
Our Capabilities
Listed Company
Assistance with capital raisings, fixed interest offers, takeovers and strategic reviews
Unlisted Company
We assist private companies looking to fund growth plans through private equity and capital raisings
Start Ups
We help take your idea to market the right way. We are not just advisors… we can also be investors through Cadmon Ventures
Vendors
We assist vendors to maximise valuation through optimal deal structuring
Investments
Our extensive partnership and vendor network means we see over 600 opportunities a year. Talk to us to see how we can help
Advisory Services
We provide expert advice on takeover defence, mergers and acquisitions
From new product launches and the expansion of existing business lines, to the development of greenfield projects and market pivots, we help our clients make the right decisions for their business. We provide bespoke solutions and the level of close client attention of a boutique firm, with a partner always present for all projects.
Cadmon Ventures
Entrepreneurship is at the heart of our company, and imbues all of the work we do.
What We Look For
-
1
We seek early stage companies in whose team, product and business model we believe and whose future we can help shape. We are not afraid to make bold bets.
-
2
We have key areas of interest for future investments – such as clean-tech, med-tech and agri-tech – but historically our approach has been largely industry-agnostic.
-
3
What we look for above all else is an attractive, scalable business opportunity that addresses a market disparity in a novel way (preferably with strong IP protection), with an executive team that we believe in, and can trust to deliver.
Our Areas of Focus
- Consumer Products
- Big Data & Analytics
- Digital Marketing Tech
- Digital Services
- Fintech & Financial Services
- 3D Manufacturing
- Virtual Reality
- Location Services
- Clean Tech
- Arg Tech
- Precision Medicine
- Med Tech
Meet our team
We are a team of businessmen and investors from various professional disciplines who develop investment opportunities across several industries, with local and foreign partners.
Corporate Team
Cameron Low
Managing Director
Before starting Cadmon, Cameron spent years working at companies such as Acorn Capital, UniSuper and Deloitte in the areas of funds management, equity and quantitative research and financial modelling. Cameron holds a Bachelors in Commerce/Science and Masters in Applied Finance both from Monash University.
Gernot Abl
Corporate Director
Gernot currently holds directorships in several start-ups in the online gaming industry. His career background is in corporate advisory, where he held roles at Deloitte Australia, assisting in the restructuring of distressed companies. Some of his previous clients included Crown, Govt of Victoria, Govt of WA, Department of Health, Western Power and Tattersalls. Gernot holds a Commerce/Law degree from the University of Western Australia.
Christopher Baillieu
Associate Analyst
Prior to Cadmon, Chris worked at stockbroking firms; Shaw and Partners and Baillieu Holst, in research departments and on the trading floors. He has also worked at National Australia Bank in their Derivatives, Securities and Regional Operations division.
Dr Bow Tauro
Lifescience Analyst
Bow holds a PhD in Biochemistry and Molecular Biology from The University of Melbourne. He has published numerous cancer research journal articles and received 900+ citations for his work. Bow has worked in university, hospital, health-tech, start-up and corporate advisory industries. He has experience in company research and analysis, advisory board consulting, business development and strategic sales.
Pat Quah
Research Analyst
Prior to Cadmon, Pat worked at Acorn Capital as an Investment Analyst covering the Financials and REITs sector. Before Acorn, Pat was at CLSA - Asia's leading and longest-running independent brokerage and investment group. At CLSA, she was the primary analyst for 3 sectors in Thailand including Consumer, Telecommunication, and Media and was voted to the No.1 analyst from Asiamoney Broker Poll in Food & Staple Retailing Sector (2010, 2012, 2013, and 2014), Food, Beverage & Tobacco Sector (2013 and 2014), and Media Sector (2013 and 2014). Pat has a Bachelor of Business Administration - Finance degree (First Class Honors) from Thammasat University.
Jo Forbes-Young
Legal Counsel
Jo has over 20 years practice in corporate advisory and commercial law and has extensive experience in advising on all aspects of business and corporate mergers and acquisitions (both private and public listed vehicles), private equity transactions, privatisation and infrastructure projects and the provision of general commercial and Corporations Act compliance advice. Prior to joining Cadmon, Jo was an Executive Director and the Chief Operating Officer at Evergreen Capital Partners. Jo has a Bachelor of Commerce and Laws degree from the University of Queensland and was a Senior Associate at Corrs Chambers Westgarth in Sydney.
Multidisciplinary Advisors
Our advisors come from a diverse range of industries and professional backgrounds. They are innovators and thought leaders in their fields who bring strong ideas and a global mindset to the table. Their vast network, broad experience and valuable insights bolster our collective success.
Dr Altay Altuntas
Orthopaedics | Medical Devices | Biotech
Dr Alturas is an internationally recognised Orthopaedic Surgeon. He adopts a holistic approach and is continually aware of new and innovative treatment styles. He has public hospital appointments at St Vincent's Hospital and the Northern Hospital and is a lecturer at the University of Melbourne and a former Senior Clinical Lecturer at Imperial College London.
Bert Huys
Green Tech | Environments
Bert has over 25 years of experience in mining, mineral processing and infrastructure development including most recently senior roles with Perth Airport and BHP Billiton Iron Ore. He serves as Research and Technology Development Manager at Keshi Technologies, a company involved in developing next generation clean-tech solutions. He is also a Honorary Research Fellow at the University of Western Australia.
Dr Jaroslav Boublik
Nutritional Science | Food & Beverage
Dr Boublink has spent over 30 years as a professional scientist and more recently as a researcher and commentator in the wellness industry. As a researcher, Dr Boublik has spent time at the CSIRO, Prince Henry’s Hospital Medical Research Centre, The Shanghai Institute of Biochemistry in China, the esteemed Salk institute in La Jolla, and the Baker Medical Research Institute in Melbourne.
Dr Michael Green
Resources | Energy
Dr Green is a geologist with over 15 years’ experience with managing all aspects of exploration programs in Australia and around the world, targeting a broad range of commodities with a focus on base and precious metals. He has also served senior executive positions on a number of ASX listed resource companies. He completed his PhD at the University of Sydney and undergraduate degree from the University of Western Australia.
Steven Reid
Pharmaceuticals | Biochemistry
Steven is experienced in pharmacology & biochemistry. He is a commercial pharmacist and pharmacy owner. He has a strong track record in providing high net worth clients, publicly listed and private biotech companies with technical consultancy services. He is also a successful Biotechnology investor, with specific areas of interest in neuro-pharmacology and cardiovascular disease. Steven is a Melbourne University and Latrobe University graduate in the fields of Pharmacology and Biochemistry.